Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Translational challenges in targeting latent HIV infection and the CNS reservoir problem.

Garrido C, Margolis DM.

J Neurovirol. 2015 Jun;21(3):222-6. doi: 10.1007/s13365-014-0269-z. Epub 2014 Jul 25. Review.

2.

Analysis of metabolic changes of brain in HIV-1 seropositive patients with proton magnetic resonance spectroscopy.

Kołtowska A, Hendrich B, Knysz B, Sokolska V, Miś M, Lubkowska K, Furdal M, Szewczyk P, Gąsiorowski J, Gładysz A, Sąsiadek M.

Pol J Radiol. 2010 Apr;75(2):27-32.

3.

The role of medical imaging in defining CNS abnormalities associated with HIV-infection and opportunistic infections.

Tate DF, Khedraki R, McCaffrey D, Branson D, Dewey J.

Neurotherapeutics. 2011 Jan;8(1):103-16. doi: 10.1007/s13311-010-0010-4. Review.

4.

Lower brain glutamate is associated with cognitive deficits in HIV patients: a new mechanism for HIV-associated neurocognitive disorder.

Ernst T, Jiang CS, Nakama H, Buchthal S, Chang L.

J Magn Reson Imaging. 2010 Nov;32(5):1045-53. doi: 10.1002/jmri.22366.

5.

Neuronal injury in simian immunodeficiency virus and other animal models of neuroAIDS.

Crews L, Lentz MR, Gonzalez RG, Fox HS, Masliah E.

J Neurovirol. 2008 Aug;14(4):327-39. doi: 10.1080/13550280802132840. Review.

6.

Factor analysis reveals differences in brain metabolism in macaques with SIV/AIDS and those with SIV-induced encephalitis.

Lentz MR, Lee V, Westmoreland SV, Ratai EM, Halpern EF, González RG.

NMR Biomed. 2008 Oct;21(8):878-87. doi: 10.1002/nbm.1276.

7.

Assessing multiple-group diagnostic problems with multi-dimensional receiver operating characteristic surfaces: application to proton MR Spectroscopy (MRS) in HIV-related neurological injury.

Yiannoutsos CT, Nakas CT, Navia BA; proton MRS Consortium.

Neuroimage. 2008 Mar 1;40(1):248-55. doi: 10.1016/j.neuroimage.2007.09.056. Epub 2007 Oct 12.

8.

Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS.

Williams K, Westmoreland S, Greco J, Ratai E, Lentz M, Kim WK, Fuller RA, Kim JP, Autissier P, Sehgal PK, Schinazi RF, Bischofberger N, Piatak M, Lifson JD, Masliah E, González RG.

J Clin Invest. 2005 Sep;115(9):2534-45. Epub 2005 Aug 18.

9.

A prospective longitudinal in vivo 1H MR spectroscopy study of the SIV/macaque model of neuroAIDS.

Fuller RA, Westmoreland SV, Ratai E, Greco JB, Kim JP, Lentz MR, He J, Sehgal PK, Masliah E, Halpern E, Lackner AA, González RG.

BMC Neurosci. 2004 Mar 5;5:10.

10.

Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV.

Simone IL, Federico F, Tortorella C, Andreula CF, Zimatore GB, Giannini P, Angarano G, Lucivero V, Picciola P, Carrara D, Bellacosa A, Livrea P.

J Neurol Neurosurg Psychiatry. 1998 Apr;64(4):516-23.

11.

Proton MRS and quantitative MRI assessment of the short term neurological response to antiretroviral therapy in AIDS.

Wilkinson ID, Lunn S, Miszkiel KA, Miller RF, Paley MN, Williams I, Chinn RJ, Hall-Craggs MA, Newman SP, Kendall BE, Harrison MJ.

J Neurol Neurosurg Psychiatry. 1997 Oct;63(4):477-82.

12.

Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy.

López-Villegas D, Lenkinski RE, Frank I.

Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9854-9.

13.

Deep gray matter structures in HIV infection: a proton MR spectroscopic study.

Meyerhoff DJ, Weiner MW, Fein G.

AJNR Am J Neuroradiol. 1996 May;17(5):973-8.

Items per page

Supplemental Content

Write to the Help Desk